Related news from
Tue, 16 Apr 2024 11:00:00 +0000	United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., April 16, 2024--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its commercial and development portfolio will be presented at the American Thoracic Society (ATS) International Conference in San Diego on May 17-22, 2024. At ATS, United Therapeutics will host an educational industry theater on implementing treprostinil induction strategies in pulmonary hypertension, and the
Wed, 10 Apr 2024 17:46:19 +0000	Innovation in Healthcare: HTEC’s Q1 2024 Index Rebalance This article examines the first index rebalance and reconstitution of 2024 for the ROBO Global Healthcare Technology and Innovation Index, which underlies the $63 million ROBO Global Healthcare Technology and Innovation ETF (HTEC). Index movements are due to scoring changes from a combination of sector trends, individual companies’ financial health, quantitative analysis, and the insights [...]
Sat, 06 Apr 2024 05:55:25 +0000	Insider Sell: Chairperson & CEO Martine Rothblatt Sells 30,000 Shares of United ... Martine Rothblatt, Chairperson & Chief Executive Officer of United Therapeutics Corp (NASDAQ:UTHR), sold 30,000 shares of the company on April 4, 2024, according to a recent SEC filing.
Fri, 05 Apr 2024 05:52:24 +0000	Insider Sell: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United Therapeutics ... Paul Mahon, EVP & GENERAL COUNSEL of United Therapeutics Corp (NASDAQ:UTHR), sold 6,000 shares of the company on April 4, 2024, according to a recent SEC filing.
Thu, 04 Apr 2024 00:02:26 +0000	3 Underappreciated Healthcare Stocks to Buy Now: April 2024 The healthcare sector is a constant source of innovation and growth. Yet, even amidst the spotlight on industry giants, a realm of underappreciated gems still exists. The top underappreciated healthcare stocks to buy offer a unique opportunity for savvy investors to capitalize on burgeoning trends and new drug discoveries. While some players may operate in niche segments, their potential for substantial returns makes them compelling growth prospects. As investors continue to seek opportunities f
Fri, 29 Mar 2024 23:00:47 +0000	United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells 29,125 Shares Martine Rothblatt, Chairperson & Chief Executive Officer of United Therapeutics Corp (NASDAQ:UTHR), has sold 29,125 shares of the company on March 28, 2024, according to a recent SEC Filing.
Fri, 29 Mar 2024 15:30:29 +0000	Why Is Jazz (JAZZ) Up 1.3% Since Last Earnings Report? Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Thu, 28 Mar 2024 15:30:39 +0000	Why Is Esperion Therapeutics (ESPR) Up 2% Since Last Earnings Report? Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Wed, 27 Mar 2024 23:00:51 +0000	United Therapeutics Corp (UTHR) CEO Martine Rothblatt Sells 30,000 Shares Martine Rothblatt, Chairperson and Chief Executive Officer of United Therapeutics Corp (NASDAQ:UTHR), sold 30,000 shares of the company on March 26, 2024, according to a recent SEC Filing.
Tue, 26 Mar 2024 14:00:02 +0000	United Therapeutics' Robust Portfolio Fuels Double-Digit Growth A closer look at one of the leaders in the pulmonary arterial hypertension treatment market
Tue, 26 Mar 2024 11:00:00 +0000	United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., March 26, 2024--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced the online availability of a review manuscript titled "Physiological Basis for Xenotransplantation from Genetically-Modified Pigs to Humans: A Review," in the journal Physiological Reviews. The manuscript is the first detailed overview of the current state of the xenotransplantation industry and, in one place, collects the vast history o
Mon, 25 Mar 2024 23:00:40 +0000	Insider Sell: United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells ... United Therapeutics Corp (NASDAQ:UTHR) Chairperson & CEO Martine Rothblatt has sold 30,000 shares of the company on March 22, 2024, according to a recent SEC Filing.
Mon, 25 Mar 2024 11:00:00 +0000	United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., March 25, 2024--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that its Board of Directors has authorized the company to purchase up to $1 billion of United Therapeutics’ common stock. This program builds on United Therapeutics’ planned $400 million paydown of its revolving credit facility in 2024, of which $100 million was paid down during the first quarter of 2024.
Fri, 22 Mar 2024 15:30:48 +0000	Why Is United Therapeutics (UTHR) Up 8.9% Since Last Earnings Report? United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Thu, 21 Mar 2024 23:01:09 +0000	United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells 30,000 Shares Martine Rothblatt, Chairperson & Chief Executive Officer of United Therapeutics Corp (NASDAQ:UTHR), has sold 30,000 shares of the company on March 20, 2024, according to a recent SEC Filing.
Sun, 17 Mar 2024 12:50:16 +0000	30 Biggest Biotechnology Companies in the World In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
Sat, 16 Mar 2024 18:42:00 +0000	Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript Liquidia Corporation (NASDAQ:LQDA) Q4 2023 Earnings Call Transcript March 13, 2024 Liquidia Corporation misses on earnings expectations. Reported EPS is $-0.42 EPS, expectations were $-0.23. LQDA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome everyone to […]
Thu, 14 Mar 2024 02:54:14 +0000	Q4 2023 Liquidia Corp Earnings Call Q4 2023 Liquidia Corp Earnings Call
Wed, 13 Mar 2024 19:12:23 +0000	The 3 Most Undervalued Nasdaq Stocks to Buy in March 2024 Growth-oriented and patient investors love undervalued NASDAQ stocks to sink their teeth into. Despite current low prices, undervalued stocks present the opportunity to reap the benefits of future growth and sell at a significantly higher price. There is much to be said about all three of these stocks, but the one thing they have in common right now is a price that is hard to believe. Following many Q4 reports last month, we looked into how well these companies are performing and the returns the
Mon, 11 Mar 2024 23:01:36 +0000	United Therapeutics Corp Chairperson & CEO Martine Rothblatt Sells 30,000 Shares Martine Rothblatt, the Chairperson & CEO of United Therapeutics Corp (NASDAQ:UTHR), sold 30,000 shares of the company on March 8, 2024, according to a recent SEC filing.